Digital dashboard aims to transform diabetes care for kids

NCT ID NCT07712809

First seen Jul 20, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests whether a digital platform called Haibu Diabetes helps children with type 1 diabetes manage their condition better. The platform collects health data from devices and shares it with patients, caregivers, and doctors through a single dashboard. Researchers will compare blood sugar control in children who use the platform versus those who do not, using surveys and clinical data to assess both effectiveness and ease of use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a digital diabetes care platform (Haibu Diabetes) that aggregates health data and provides a shared dashboard for patients, caregivers, and healthcare providers
What this could lead to
If effective, this digital tool could improve blood sugar control and quality of life for children with type 1 diabetes by enhancing communication and self-management.
What could go wrong
This is a small, non-randomized study, so results may not apply broadly. The platform's impact may be limited by user engagement or technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BC Children's Hospital

    Vancouver, British Columbia, V6H3N1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.